Back to GetFilings.com



Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC. 20549


FORM 10-Q

(Mark One)
x    Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended September 30, 2002
 
or     
 
o    Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from ____________ to ____________

Commission File Number 0-24085


AXT, INC.
(Exact name of registrant as specified in its charter)

     
DELAWARE
(State or other jurisdiction of
Incorporation or organization)
  94-3031310
(I.R.S. Employer
Identification No.)

4281 Technology Drive, Fremont, California 94538
(Address of principal executive offices) (Zip code)
(510) 683-5900
(Registrant’s telephone number, including area code)


     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
YES x     NO o

     Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

     
Class   Outstanding at September 30, 2002

 
Common Stock, $.001 par value   22,495,094



1


TABLE OF CONTENTS

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements
CONDENSED CONSOLIDATED BALANCE SHEETS
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Qualitative and Quantitative Disclosures About Market Risk
Item 4. Evaluation of Disclosure Controls and Procedures
PART II OTHER INFORMATION
Item 1. Legal Proceedings
Item 2. Changes in Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Submission of Matters to a Vote of Security Holders
Item 5. Other Information
Item 6. Exhibits and Reports on Form 8-K
SIGNATURES
Index to Exhibits
EXHIBIT 10.14
EXHIBIT 99.1
EXHIBIT 99.2


Table of Contents

AXT, INC.

TABLE OF CONTENTS

             
            Page
           
PART I.   FINANCIAL INFORMATION    
 
    Item 1.   Financial Statements    
 
        Condensed Consolidated Balance Sheets at September 30, 2002 and December 31, 2001   3
 
        Condensed Consolidated Income Statements for the three and nine months ended September 30, 2002 and 2001   4
 
        Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2002 and 2001   5
 
        Notes To Condensed Consolidated Financial Statements   6-13
 
    Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   14-33
 
    Item 3.   Quantitative and Qualitative Disclosures About Market Risk   34
 
    Item 4.   Evaluation of Disclosure Controls and Procedures   35
 
PART II.   OTHER INFORMATION    
 
    Item 1.   Legal Proceedings   35
 
    Item 6.   Exhibits and Reports on Form 8-K   35-36
 
        Signatures   37
 
        Certifications   37-39

2


Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

AXT, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)

                       
          September 30,   December 31,
          2002   2001
         
 
          (Unaudited)        
Assets:
               
 
Current assets
               
   
Cash and cash equivalents
  $ 12,647     $ 37,538  
   
Short-term investments
    4,591       25,673  
   
Accounts receivable
    11,868       15,684  
   
Inventories
    50,570       55,587  
   
Prepaid expenses and other current assets
    6,023       3,577  
   
Income tax receivable
    7,721        
   
Deferred income taxes
          10,557  
 
   
     
 
     
Total current assets
    93,420       148,616  
 
Property, plant and equipment
    47,189       82,573  
 
Restricted deposits
    10,315        
 
Long-term investments
    6,906       6,552  
 
Other assets
    5,104       4,511  
 
Goodwill
          1,107  
 
   
     
 
     
Total assets
  $ 162,934     $ 243,359  
 
   
     
 
Liabilities and Stockholders’ Equity:
               
 
Current liabilities
               
   
Accounts payable
  $ 4,902     $ 2,943  
   
Accrued liabilities
    10,025       13,362  
   
Income tax payable
    3,000       308  
   
Current portion of long-term debt
    957       2,336  
   
Current portion of capital lease obligation
    3,971       4,372  
 
   
     
 
     
Total current liabilities
    22,855       23,321  
   
Long-term debt, net of current portion
    10,236       14,342  
   
Long-term capital lease, net of current portion
    5,783       10,002  
   
Other long-term liabilities
    1,567       1,273  
   
Deferred income taxes
          8,099  
 
   
     
 
     
Total liabilities
    40,441       57,037  
 
   
     
 
 
Stockholders’ equity:
               
   
Preferred stock, $.001 par value; 2,000 shares authorized; 883 shares issued and outstanding
    3,532       3,532  
   
Common stock, $.001 par value per share; 70,000 shares authorized; 22,495 and 22,383 shares issued and outstanding
    154,485       153,635  
   
Retained earnings
    (34,665 )     28,984  
   
Other comprehensive income
    (859 )     171  
 
   
     
 
     
Total stockholders’ equity
    122,493       186,322  
 
   
     
 
   
Total liabilities and stockholders’ equity
  $ 162,934     $ 243,359  
 
   
     
 

See accompanying notes to these unaudited condensed consolidated financial statements.

3


Table of Contents

AXT, INC.
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(In thousands, except per share data)

                                     
        Three Months Ended   Nine Months Ended
        September 30,   September 30,
       
 
        2002   2001   2002   2001
       
 
 
 
Revenue
  $ 14,948     $ 22,783     $ 50,919     $ 104,159  
Cost of revenue
    18,491       17,423       51,241       66,300  
 
   
     
     
     
 
Gross profit (loss)
    (3,543 )     5,360       (322 )     37,859  
Operating expenses:
                               
 
Selling, general and administrative
    4,993       5,826       14,853       17,105  
 
Research and development
    1,308       1,701       3,756       6,834  
 
Property, plant and equipment and goodwill impairment loss
    15,107             39,086        
 
   
     
     
     
 
   
Total operating expenses
    21,408       7,527       57,695       23,939  
 
   
     
     
     
 
Income (loss) from operations
    (24,951 )     (2,167 )     (58,017 )     13,920  
Interest expense
    364       493       1,114       1,637  
Other (income)/expense
    (303 )     (488 )     8,188       (1,542 )
 
   
     
     
     
 
Income (loss) before provision for income taxes
    (25,012 )     (2,172 )     (67,319 )     13,825  
Provision expense (benefit) for income taxes
    3,661       (782 )     (3,670 )     4,977  
 
   
     
     
     
 
Net income (loss)
  $ (28,673 )   $ (1,390 )   $ (63,649 )   $ 8,848  
 
   
     
     
     
 
Basic income (loss) per share
    (1.28 )     (0.06 )     (2.84 )     0.40  
Diluted income (loss) per share
    (1.28 )     (0.06 )     (2.84 )     0.39  
Shares used in per share calculations:
                               
 
Basic
    22,478       22,333       22,443       22,246  
 
Diluted
    22,478       22,333       22,443       22,931  

See accompanying notes to these unaudited condensed consolidated financial statements.

4


Table of Contents

AXT, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In thousands)

                         
            Nine Months Ended
            September 30,
           
            2002   2001
           
 
CASH FLOWS FROM OPERATING ACTIVITIES:
               
 
Net income (loss):
  $ (63,649 )   $ 8,848  
 
Adjustments to reconcile net income (loss) to cash provided by (used in) operations:
               
   
Depreciation
    7,498       6,187  
   
Deferred income taxes
    3,259        
   
Amortization
    299       266  
   
Stock compensation
          83  
   
Impairment write-down on marketable equity securities
    9,160        
   
Non-cash (gain)\loss on marketable equity securities
    (251 )      
   
Loss on disposal of property, plant and equipment
    323        
   
Impairment loss on property, plant and equipment and goodwill
    39,086        
   
Changes in assets and liabilities:
               
     
Accounts receivable
    3,816       4,624  
     
Inventories
    5,017       (6,692 )
     
Prepaid expenses
    (2,341 )     (228 )
     
Other assets
    (125 )     (120 )
     
Accounts payable
    1,959       (1,532 )
     
Accrued liabilities
    (3,336 )     3,256  
     
Income taxes
    (5,031 )      
     
Other long-term liabilities
    294       64  
 
   
     
 
       
Net cash (used in) provided by operating activities
    (4,022 )     14,756  
 
   
     
 
CASH FLOWS FROM INVESTING ACTIVITIES:
               
 
Purchases of property, plant and equipment
    (10,412 )     (24,321 )
 
Purchases of marketable securities
    (16,366 )     (22,748 )
 
Proceeds from sale of marketable securities
    15,570       1,034  
 
   
     
 
       
Net cash used in investing activities
    (11,208 )     (46,035 )
 
   
     
 
CASH FLOWS FROM FINANCING ACTIVITIES:
               
 
Proceeds from (payments of):
               
   
Issuance of common stock
    850       4,612  
   
Capital leases borrowings
          3,143  
   
Capital leases payments
    (4,620 )     (3,231 )
   
Short-term debt payments
          (966 )
   
Long-term debt borrowings
    637        
   
Long-term debt payments
    (6,699 )     (2,171 )
 
   
     
 
       
Net cash (used in) provided by financing activities
    (9,832 )     1,387  
Effect of exchange rate changes
    171       130  
 
   
     
 
Net decrease in cash and cash equivalents
    (24,891 )     (29,762 )
Cash and cash equivalents at the beginning of the period
    37,538       68,585  
 
   
     
 
Cash and cash equivalents at the end of the period
  $ 12,647     $ 38,823  
 
   
     
 
Non cash activity:
               
 
Purchase of property, plant and equipment through financing
  $ 577     $ 2,170  
 
   
     
 

See accompanying notes to these unaudited condensed consolidated financial statements.

5


Table of Contents

AXT, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

Note 1. Basis of Presentation

     The accompanying condensed consolidated balance sheets as of September 30, 2002 and December 31, 2001, the condensed consolidated income statements for the three and nine months ended September 30, 2002 and 2001, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2002 and 2001 have been prepared by AXT, Inc. (“AXT” or the “Company”) and are unaudited. The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, certain information and footnote disclosure normally included in financial statements prepared in accordance with generally accepted accounting principles in the United States have been condensed or omitted. In the opinion of management, the unaudited condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, considered necessary to present fairly the financial position, results of operations and cash flows of AXT and its subsidiaries for all periods presented.

     Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these condensed consolidated financial statements in conformity with generally accepted accounting principles. Actual results could differ materially from those estimates.

     The results of operations are not necessarily indicative of the results to be expected in the future or for the full fiscal year. It is recommended that these condensed consolidated financial statements be read in conjunction with the Company’s consolidated financial statements and the notes thereto included in its 2001 Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 26, 2002.

     Certain reclassifications have been made to the prior years consolidated financial statements to conform to current period presentation.

Note 2. Gain on Demeter Warrants

     In August 2000, the Company entered into a business transfer and acquisition agreement with Demeter Technologies, Inc., a Delaware corporation founded by Theodore S. Young, the former president of the Company’s fiber optic division and a former member of the Company’s board of directors, and Robert Shih, the former chief technology officer of the Company’s opto-electronics division. Under this agreement, the Company agreed to transfer certain non-core rights to Demeter relating to research and development activities in the field of fiber optics. The Company entered into non-competition agreements with Messrs. Shih and Young that prohibit them from certain activities, including the manufacture of certain VCSEL devices. The Company leased to Demeter a portion of its owned facility in El Monte, California, subleased a portion of its rented facility in El Monte, California, leased certain equipment, including an MOCVD machine, and sold certain inventory relating to fiber optics to Demeter. In exchange, Demeter granted to the Company a warrant to purchase up to 4.5 million shares of its Series A convertible preferred stock at a price of $0.5714 per share. Demeter was purchased by Finisar Corporation and as a result, AXT converted its Demeter warrant for approximately 1.1 million shares of Finisar Corporation common stock on November 21, 2000. On November 21, 2000, a gain of $27.3 million was recorded in other income as a result of the transaction. On December 10, 2001, the Company received approximately 86,000 additional shares of common stock of Finisar Corporation that had been held in escrow in accordance with the terms of the acquisition agreement between Demeter and Finisar. A gain of $1.1 million was recorded in other income as a result of receiving these additional shares. On December 31, 2001, the Company wrote its investment in Finisar Corporation down to current market value, in accordance with SFAS 115, resulting in a realized loss of $16.7 million recorded in other income and expense. On February 4, 2002, the Company received approximately 24,000 additional shares of common stock of Finisar Corporation that had been held in escrow in accordance with the terms of the acquisition agreement between Demeter and Finisar. A gain of $251,000 was recorded in other income as a result of receiving these additional shares. The investment in Finisar Corporation common stock is accounted for as available for sale and

6


Table of Contents

classified as a short-term investment. On June 30, 2002, the Company wrote its investment in Finisar Corporation down to current market value, in accordance with SFAS 115, resulting in a realized loss of $9.2 million recorded in other income and expense.

Note 3. Long-Lived Asset Impairment

     In the second quarter of 2002, the Company completed an impairment review of certain manufacturing assets used in the substrate and opto-electronics divisions. The review was undertaken due to the recent history of operating losses, declines in the demand for our products due to macro economic conditions and excess capacity resulting in part from the relocation of certain manufacturing operations in the Company’s substrate division to China.

     Upon completion of the review, the Company determined that the carrying value of the manufacturing assets was not expected to be recoverable and accordingly recorded an impairment charge in order to write-down the related assets to their estimated fair value. The Company determined the amount of the impairment charge by estimating the net present value of expected future cash flows to be generated by the assets. Based on this analysis, the Company recorded non-cash impairment charges of $14.1 million in the substrate segment and $9.9 million in the opto-electronics segment for the laser diode operating unit.

     In the third quarter of 2002, the Company completed an impairment review of certain manufacturing assets in the opto-electronics division. The review was undertaken due to the unexpected operating losses incurred in the third quarter, declines in product demand due to the Company’s inability to manufacture high volumes of its LED products to the Company’s customers’ requirements, and the need for the Company to reduce its current level of production to conserve cash.

     Upon completion of the review, the Company determined that the carrying value of the manufacturing assets was not expected to be recoverable and accordingly recorded an impairment charge in order to write-down the related assets to their estimated fair value. The Company determined the amount of the impairment charge by estimating the net present value of expected future cash flows to be generated by the assets. Based on this analysis, the Company recorded a non-cash impairment charge of $14.0 million.

Note 4. Goodwill Impairment

     The Company adopted the provisions of SFAS 142, “Goodwill and Other Intangible Assets,” effective January 1, 2002. Under the transition provisions of SFAS No. 142, there was no goodwill impairment at January 1, 2002 based upon the Company’s analysis at that time. However, during the quarter ended September 30, 2002, circumstances developed that indicated that the goodwill was likely impaired and the Company performed an impairment analysis as of September 30, 2002. This analysis resulted in a $1.1 million impairment of goodwill. The circumstances that led to the impairment included a net loss for the quarter and a significant drop in the Company’s market capitalization.

Note 5. Investments

     The Company classifies all of its investment securities as available-for-sale securities as prescribed by Statement of Financial Accounting Standards No. 115, “Accounting for Certain Investments in Debt and Equity Securities,” and does not hold any debt securities with the positive intent and ability to hold to maturity, or trading securities bought and held principally for the purpose of selling in the near term. All investments considered to be strategic in nature are carried at fair value, which is determined based on quoted market prices, with net unrealized gains and losses included in comprehensive income, net of tax. The components of investments at September 30, 2002 are summarized below (in thousands):

7


Table of Contents

                         
            Aggregate   Unrealized
Available for sale   Cost   Fair value   Gain/(loss)

 
 
 
Money market
  $ 6,434     $ 6,434     $  
Corporate bonds
    17,321       17,476       155  
Government agency bonds
    3,502       3,526       24  
Corporate equity securities
    2,782       810       (1,972 )
 
   
     
     
 
 
  $ 30,039     $ 28,246     $ (1,793 )
 
   
     
     
 
Recorded as:
                       
Cash equivalents
  $ 6,434